Rogers, Minnesota -- Biomaterials and medical device company AorTech International plc has started making standard polymer products to satisfy customer orders in its Rogers, Minnesota factory. Production of AorTech's entire range of polymers will take place throughout the remainder of 2011 and into early 2012, having moved from its former location in Scoresby, Victoria, in Australia.
Frank Maguire, AorTech ceo commented that routine manufacturing of the patented urethane and silicone based polymer products is "an important milestone in the transition of the company's relocation of production to Rogers."
Contractors designed the facility, oversaw its construction and successfully navigated through the numerous issues encountered in the inspection and permitting phase of this project. The project began in mid-July and is now - less than 90 days later, in the operational phase, producing polymers for sale to our customers. We are off to a good start in our new home."
AorTech develops and manufactures biostable, implantable polymers, including Elast-Eon (urethane-based) and ECSil (silicone-based), the world's leading long-term implantable co-polymers, as well as proprietary processing methods for various devices, including small part manufacturing by reaction injection moulding.
Aortech originally manufactured in Scotland, before moving production in 2004 to Australia, where Elast-Eon was first developed, at Australia's national science agency, CSIRO (Commonwealth Scientific and Industrial Research Organisation).